KalVista Pharmaceuticals (KALV)
(Real Time Quote from BATS)
$12.86 USD
-0.04 (-0.31%)
Updated Aug 12, 2024 09:56 AM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 9/5/24 |
---|---|
Current Quarter | -0.93 |
EPS Last Quarter | -1.02 |
Last EPS Surprise | -43.66% |
ABR | 1.17 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.38 |
Next Year | -1.50 |
EPS (TTM) | -3.40 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 2.07M | 28.12M | 121.59M |
# of Estimates | NA | 1 | 2 | 2 |
High Estimate | NA | 2.07M | 35.51M | 149.08M |
Low Estimate | NA | 2.07M | 20.72M | 94.09M |
Year ago Sales | 0.00M | 0.00M | NA | 28.12M |
Year over Year Growth Est. | NA | NA | NA | 332.46% |
Earnings Estimates
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.93 | -0.96 | -3.38 | -1.50 |
# of Estimates | 3 | 3 | 5 | 2 |
Most Recent Consensus | -0.90 | -0.91 | -3.54 | -2.25 |
High Estimate | -0.86 | -0.86 | -3.16 | -0.75 |
Low Estimate | -1.02 | -1.12 | -3.54 | -2.25 |
Year ago EPS | -0.74 | -0.80 | -3.44 | -3.38 |
Year over Year Growth Est. | -25.68% | -20.00% | 1.74% | 55.62% |
Agreement - Estimate Revisions
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 2 | 3 | 2 |
Down Last 60 Days | 2 | 2 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Current | -0.93 | -0.96 | -3.38 | -1.50 |
7 Days Ago | -0.93 | -0.96 | -3.38 | -1.50 |
30 Days Ago | -0.65 | -0.64 | -2.65 | -0.68 |
60 Days Ago | -0.65 | -0.64 | -2.65 | -0.68 |
90 Days Ago | -0.65 | -0.64 | -2.49 | -0.68 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.93 | -0.96 | -3.48 | -1.50 |
Zacks Consensus Estimate | -0.93 | -0.96 | -3.38 | -1.50 |
Earnings ESP | 0.00% | 0.00% | -2.86% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (4/2024) |
Quarter Ending (1/2024) |
Quarter Ending (10/2023) |
Quarter Ending (7/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.02 | -0.84 | -0.80 | -0.74 | NA |
Estimate | -0.71 | -0.75 | -0.71 | -0.83 | NA |
Difference | -0.31 | -0.09 | -0.09 | 0.09 | -0.10 |
Surprise | -43.66% | -12.00% | -12.68% | 10.84% | -14.38% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more